Individualizing Diabetes Management in Early T2DM
  • CME
  • CE

Learn to establish appropriate glycemic targets and interpret guideline recommendations on when and how to advance diabetes therapy to reduce CV risk in this CME-certified module.
Guillermo E. Umpierrez, MD, CDE
Physicians: maximum of 1.0 AMA PRA Category 1 Credit
Registered Nurses: 1.0 Nursing contact hour
Released: December 5, 2018 Expiration: December 4, 2019

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Determine an appropriate A1C goal that reflects patient factors such as age, duration of T2DM, life expectancy, comorbidities, and risk of hypoglycemia
  • Apply key learnings from T2DM published guidelines and pivotal clinical study results to develop strategies for intensifying therapy in patients who fail to achieve glycemic control on initial therapy
  • Consider findings of cardiovascular outcomes trials when selecting T2DM regimens for patients with elevated cardiovascular risk

Information on this Educational Activity

Southern Medical Association (SMA) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to SMA policy. SMA is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:


Guillermo E. Umpierrez, MD, CDE

Professor of Medicine
Emory University
Section Head, Diabetes & Endocrinology
Grady Health System
Atlanta, Georgia

Guillermo E. Umpierrez, MD, CDE, has disclosed that he has received funds for research support paid to his institution from Merck, Novo Nordisk, and Sanofi and has served on advisory boards for Merck and Sanofi.


Zachary Schwartz, MSc

Scientific Director

Zachary Schwartz, MSc, ELS, has no real or apparent conflicts of interest to report.
Megan K. Murphy, PhD

Associate Scientific Director

Megan K. Murphy, PhD, has no real or apparent conflicts of interest to report.
Jenny Schulz, PhD

Director, Scientific Services

Jenny Schulz, PhD, has no real or apparent conflicts of interest to report.

The following nurse planner, Alyce Kuklinski, NP, RN has no real or apparent conflicts of interest to report.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Target Audience

This program is intended for endocrinologists, cardiologists, primary care physicians, hospitalists, physician assistants, nurse practitioners, pharmacists, certified diabetes educators, and other healthcare providers who care for patients with type 2 diabetes.


The goal of this activity is to improve participants’ clinical competence in preventing T2DM and at applying culturally competent treatment strategies in the management of patients with T2DM and associated cardiovascular risks.

Physician Continuing Medical Education

Southern Medical Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

American Medical Association Physician’s Recognition Award (AMA)

Southern Medical Association designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.

American Board of Internal Medicine - Maintenance of Certification Knowledge Points

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC knowledge points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

If you are interested in having us report ABIM MOC, please ensure the following information is provided within your Member Profile:

  • Name - as registered with ABIM
  • Date of Birth (Month/Day)
  • Your ABIM Number

Nursing Continuing Education

Credit Designation

1.0 contact hour may be earned for successful completion of this activity.

Accreditation Statement

This continuing nursing education activity was approved by the Alabama State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.0 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from December 05, 2018, through December 04, 2019:

1. Register online at
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Related Content

CME: Type 2 diabetes management: Dr. Veronica K. Piziak on NPH, regular insulin, switching to avoid hypoglycemia/reduce CV risk in T2DM

Veronica K. Piziak, MD, PhD, FACP
Program Director
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Released: January 11, 2019 Expiration: January 10, 2020

Type 2 diabetes management: Dr. Veronica K. Piziak on NPH, regular insulin, switching to avoid hypoglycemia/reduce CV risk in T2DM

Veronica K. Piziak, MD, PhD, FACP
Program Director
Released: December 10, 2018

Drs. Jacobson and Newsome summarize the most important NAFLD/NASH data from AASLD 2018: Noninvasive screening, clinical outcomes, emerging treatments.

Ira M. Jacobson, MD Philip N. Newsome, PhD, FRCPE Released: December 3, 2018

Audio from Zobair Younossi on NAFLD/NASH data from the 2018 liver meeting in San Francisco: noninvasive tests, patient outcomes, emerging phase II treatments

Zobair Younossi Headshot Zobair M. Younossi, MD, MPH, FACP, FACG, AGAF, FAASLD Released: November 27, 2018
Provided by Southern Medical Association
Southern Medical Association logo

Southern Medical Association, CME Division
3500 Blue Lake Drive, Suite 360
Birmingham, AL 35243
Tel: 800.423.4992, ext. 620

Supported by an educational grant from
Lilly USA, LLC

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?